Enfuego Therapeutics is developing novel RNA interference-(RNAi)-based and antisense oligo therapeutics.
Company Details
Company type
Year founded
2019
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)